Stoddard Research Group
The “Molecular Immunotherapeutics Research” (MIR) lab research program focuses on developing novel therapeutics for cancer, neurological disorders (ND), and autoimmune disorders (AD), in addition to studying proteins associated with these diseases. We use rational drug design to develop therapeutics which can target proteins involved in these diseases. We address these goals using both computational and experimental work.
Currently the MIR lab is working on four projects involving a combination of techniques such as experimental biochemistry techniques, organic synthesis, and computational methods to engineer proteins and design small compounds that could assist in treatment of these disorders.
Project 1: Development of Antigen Specific Therapeutics and Novel Therapeutic Approaches of Autoimmune Disorders
Project 2: Modelling and Investigation of Structure and Function Relationships of Unsolved Protein Structures Involved in Autoimmune, Cancer, or Neurological Disease Pathogenesis
Project 3: Design, Synthesis, and Biological Testing of Novel Compounds having Improved Performance as Cancer Therapeutics
Project 4: Design, Synthesis and Biological Testing of Novel Therapeutics for Neurological Disorders